Found 15 matching trials
SHR-A1811 Alone or in Combination With Adebrelimab as Neoadjuvant Treatment in HR Positive/HER2 Low Breast Cancer PHASE2 This is an open-label, phase II study evaluating the efficacy and safety of...
Show More Location
Shengjing Hospital affiliated to China Medical University
Learn More & Join Trial
A Phase III Study of SHR-A1811 in Combination With Chemotherapy and Adebrelimab in Previously Untreated Patients With Gastric or Gastroesophageal Junction Adenocarcinoma PHASE3 This study aims to evaluate the efficacy and safety of SHR-A1811 combined w...
Show More Location
The First Hospital of China Medical University
Learn More & Join Trial
Chemotherapy With or Without Adebrelimab and T-DXh as Neoadjuvant Therapy for HR+/HER2 Low Early Stage Breast Cancer PHASE2 The goal of this clinical trial is to learn if add SHR-A1811 and/or Adebrel...
Show More Location
National Cancer Center/Cancer hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Learn More & Join Trial
Establishment of Precision Targeted Therapy Strategies for Advanced Gastric Cancer Based on Novel Molecular Subtyping PHASE2 This study is a prospective, umbrella-design, Phase II clinical trial. Elig...
Show More Location
Multiple Locations
Learn More & Join Trial
Study of ADCs Combined With Adebrelimab in HER2-negative Advanced Breast Cancer PHASE2 Our study is aimed to evaluate the efficacy and safety of novel ADCs named ...
Show More Location
Beijing GoBroad Hospital
Learn More & Join Trial
A Clinical Study of SHR-A1811 Combined With Chemotherapy for Platinum Sensitive Recurrent Ovarian Cancer PHASE1 The objective is to evaluate the tolerance, safety, pharmacokinetic charact...
Show More Location
Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology
Learn More & Join Trial
A Trial of HRS-4508 Combined With Other Antitumor Therapies in Subjects With Locally Advanced or Metastatic Non-small Cell Lung Cancer PHASE2 The study is being conducted to evaluate the efficacy, safety, and ORR of H...
Show More Location
Shanghai Chest Hospital
Learn More & Join Trial
SHR-A1811 in Combination With Adebrelimab for the Treatment of HER2 Low-expressing Metastatic Breast Cancer PHASE2 To evaluate the efficacy and safety of the SHR-A1811 in combination with Ad...
Show More Location
National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital
Learn More & Join Trial
A Study of SHR-A1811 Combined With Adebelimumab as Neoadjuvant Therapy for Resectable HER2-Altered Non-Small Cell Lung Cancer PHASE2 This is a prospective, single-arm, multi-center Phase II clinical trial des...
Show More Location
Multiple Locations
Learn More & Join Trial
Phase II Study of Trastuzumab Rezetecan or in Combination With Adebrelimab in HER2-Expressing Locally Advanced or Metastatic Urothelial Carcinoma (la/mUC) PHASE2 This is a multicenter, open-label, Phase II clinical trial to evaluate the ...
Show More Location
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Learn More & Join Trial